Michael Sumner | Chief Medical Officer
Inovio Pharmaceuticals
Dr. Sumner is responsible for setting the development strategy and overseeing the execution of the company’s DNA Medicine portfolio. He brings over 30 years of extensive pharmaceutical, medical and clinical experience driving numerous late-stage product approvals and supporting successful commercial products on a global basis across multiple therapeutic areas.
Appearances:
Day 2 - World Orphan Drug Congress USA 2026 @ 12:00
Showcase 3: Rare Disease Protein Replacement Therapeutics: The transformational Potential of Next Gen DNA Medicine
last published: 13/May/26 12:45 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events